MAMohamed Ibrahim Abo-Alkasem

Mohamed Ibrahim Abo-Alkasem

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mohamed Ibrahim Abo-Alkasem has a total of 37 co-authors. Here are the top co-authors by number of shared publications:

  • Hassan Mohamed Awad

    Chemistry of Microbial and Natural ProductsDepartment1, National Research Centre (NRC); Dokki, Cairo, Egypt

    2 shared publications
  • Abdallah S. Abdelsattar

    Affiliations Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, United States of America, Center for One Health Research, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, United States of America

    1 shared publication
  • Abdelnasser Salah Shebl Ibrahim

    Department of chemisrty of natural and Microbial prodycts; Pharmaceutical and drug industries research institute; National Research Centre, Cairo; Egypt

    1 shared publication
  • Ahmed A. El. Shanshory

    Composites and Nanostructured Materials Research Department, Advanced Technology and New Materials Research Institute (ATNMRI), City of Scientific Research and Technological Applications (SRTA-City), New Borg Al-Arab, Alexandria 21934, Egypt

    1 shared publication
  • Ahmed I. El-Diwany

    Natl Res Ctr, Pharmaceut & Drug Ind Res Inst, Dept Chem Nat & Microbial Prod, Dokki, Egypt

    1 shared publication
  • AhmedA El-Beih

    Natl Res Ctr, Pharmaceut & Drug Ind Res Div, Chem Nat & Microbial Prod Dept, Giza, Egypt

    1 shared publication

Latest Publications

  • Open Access

    Topically Applied Biopolymer-Based Tri-Layered Hierarchically Structured Nanofibrous Scaffold with a Self-Pumping Effect for Accelerated Full-Thickness Wound Healing in a Rat Model

    by Kholoud H. Hamza, Ahmed A. El-Shanshory, Mona M. Agwa, Mohamed I. Abo-Alkasem, Esmail M. El-Fakharany, Abdallah S. Abdelsattar, Ali A. El-Bardan, Taher S. Kassem, Xiumei Mo, Hesham M. A. Soliman

    Wound healing has grown to be a significant problem at a global scale. The lack of multifunctionality in most wound dressing-based biopolymers prevents them from meeting all clinical requirements. Therefore, a multifunctional biopolymer-based tri-layered hierarchically nanofibrous scaffold in wound dressing can contribute to skin regeneration. In this study, a multifunctional antibacterial biopolymer-based tri-layered hierarchically nanofibrous scaffold comprising three layers was constructed. The bottom and the top layers contain hydrophilic silk fibroin (SF) and fish skin collagen (COL), respectively, for accelerated healing, interspersed with a middle layer of hydrophobic poly-3-hydroxybutyrate (PHB) containing amoxicillin (AMX) as an antibacterial drug. The advantageous physicochemical properties of the nanofibrous scaffold were estimated by SEM, FTIR, fluid uptake, contact angle, porosity, and mechanical properties. Moreover, the in vitro cytotoxicity and cell healing were assessed by MTT assay and the cell scratching method, respectively, and revealed excellent biocompatibility. The nanofibrous scaffold exhibited significant antimicrobial activity against multiple pathogenic bacteria. Furthermore, the in vivo wound healing and histological studies demonstrated complete wound healing in wounded rats on day 14, along with an increase in the expression level of the transforming growth factor-β1 (TGF-β1) and a decrease in the expression level of interleukin-6 (IL-6). The results revealed that the fabricated nanofibrous scaffold is a potent wound dressing scaffold, and significantly accelerates full-thickness wound healing in a rat model.


  • Top Cited Papers
    Open Access

    Microbial bioremediation as a tool for the removal of heavy metals

    by Mohamed I. Abo-Alkasem, Ne’mat H. Hassan, Mostafa Mostafa Abo Elsoud

    Background: The demand for designing a new technology that can emphasize the complete removal of heavy metals increased as a result of the industrial revolution. Bioremediation was found to have a potent impact on the degradation of organic and inorganic environmental pollutants. Main body: Bioremediation is a multidisciplinary technology that possesses safe, efficient, and low-cost characteristics. Also, one of the important features of bioremediation technology is the in-situ treatment which reduces the possibility of transmitting the contaminants to another site. The application of genetic engineering, to engineer a microorganism to acquire the ability to remove different types of heavy metals at a time or to generate a transgenic plant, is considered one of the new promising bioremediation approaches. Short conclusion: Removal of heavy metal pollution still represents a big challenge for ecologists that’s why this review shed some light on bioremediation technology; its importance, mechanism of action, and prospects.


  • Lactic acid bacteria

    by Nagwa A. Atwa, Marwa I. Wahba, Dina A. Maany, Hassan M. Awad, Mohamed I. Abo-Alkasem, Hossam M. El-Masry, Mai N. Amer, Ahmed I. El-Diwany

    Background: In a previous study, a lactic acid bacterium, Enterococcus faecium, was locally isolated from Egyptian soil and its ability to inhibit the growth of a test phytopathogen was proven. Objective: The study was performed to assess the ability of the tested strain to grow on different media. The produced antifungal agent was investigated. Finally, the strain was encapsulated within different biopolymers to increase its viability. Materials and methods: Several byproducts were tested and compared with the standard De Man-Rogosa-Sharpe medium. The antifungal activity was tested using the poisoned food technique. Chromatographic analysis of the fermentation medium was performed using high-performance liquid chromatography. Production of chitinase was confirmed by cultivating the test strain on chitin and estimating the amount of reducing sugars using the Somogyi method. The E. faecium cells were also encapsulated within soy protein isolate-alginate beads, gellan gum discs, and carboxymethyl cellulose beads. Results and conclusion: The strain was able to grow on all of the tested byproducts and exerted a potent antifungal activity against Fusarium solani, especially when a very economic medium, mainly composed of whey, was used. High-performance liquid chromatography results confirmed the production of a number of organic acids that contributed in the inhibition of the fungal growth. The study also proved the production of chitinase enzymes, which apparently altered the chitinous layer present in the cell wall of F. solani, causing disintegration of the fungal cells. It was also shown that encapsulation of E. faecium increased its viability in soil as compared with the free uncapsulated strain.


  • Bioreduction of hexavalent chromium by a novel haloalkaliphilic Salipaludibacillus agaradhaerens strain NRC-R isolated from hypersaline soda lakes

    by Mohamed Ibrahim Abo-Alkasem, Dina A. Maany, Mostafa A. El-Abd, Abdelnasser S. S. Ibrahim

    A novel Cr(VI)-resistant haloalkaliphilic bacterial strain NRC-R, identified as Salipaludibacillus agaradhaerens, was isolated from hypersaline soda lakes and characterized for its Cr(VI) bioreduction efficiency. Strain NRC-R grew well and effectively reduced Cr(VI) under a wide range of sodium chloride, pH, shaking velocity and temperature, showing maximum Cr(VI) reduction at 8% NaCl, pH 10, 150 rpm and 35 °C, respectively. Strain NRC-R was able to grow and reduce Cr(VI) effectively in the presence of different heavy metals and oxyanions (Pb2+, Zn2+, Co2+, Mn2+, Ni2+, Mo2+, HPO4−, NO3−, SO42− and HCO3−). Furthermore, Fe3+ and Cu2+ significantly enhanced the Cr(VI) removal by about 1.5 fold. Strain NRC-R could reduce Cr(VI) using a variety of electron donors, exhibiting a maximum reduction in the presence of NADH and fructose. The bioremoval of Cr(VI) using strain NRC-R was due to direct enzymatic reduction and the chromate reductase activity was mainly detected in the bacterial cell membrane. Under the optimized conditions, strain NRC-R showed a remarkable Cr(VI) bioreduction with highest reduction rate of 240 uM/h. Cr(VI) concentrations of up to 3 mM (888.5 mg/L) and 4 mM (1177 mg/L) were completely reduced within 16 h and 32 h, respectively. TEM and SEM–EDX analyses confirmed the biosorption of chromium species into the cells. To the best of our knowledge, this is the first report about Cr(VI) reduction by S. agaradhaerens. In conclusion, S. agaradhaerens NRC-R was a highly efficient Cr(VI) reducing haloalkaliphilic bacterium that has a significant potential in the bioremediation of Cr(VI)-contaminated environments.


  • Open Access

    Enhancement of bioethanol production by Saccharomyces cerevisiae under high gravity fermentation using sequential optimization strategy

    by Heba Mohammed, Mohamed I. Abo-Alkasem, Ehab M. Ammar, Tarek E. Mazeed, Amira M Abu Taleb

    Using high gravity fermentation for bioethanol production by Saccharomyces cerevisiae is faced with many challenges such as increasing osmotic stress and viscosity. Unfortunately, increasing specific gravity was accompanied by a decrease in fermentation efficiency. A two-stage sequential optimization strategy was carried out to solve this problem. The first stage was carried out using the Plackett-Burman Design in which eight factors were investigated at three molasses specific gravities (1.130, 1.145, 1.160). Urea, wheat bran, soy flour, and inoculum size were significant model terms and had positive effect on bioethanol production. When a validation test was performed using the predicted conditions, about a more than two-fold increase in fermentation efficiency (FE) was achieved (83%) at specific gravity 1.130, compared to the basal condition. The second stage (Taguchi Design) was conducted using eight factors. Urea, wheat bran, temperature, and agitation speed showed a significant effect on fermentation efficiency. A validation test was carried out and up to 83.82 % fermentation efficiency was recorded, which was very close to that achieved under normal gravity. In addition to the high value of FE, this strategy is cost-effective and time-saving.


  • Design and Synthesis of New CDK2 Inhibitors Containing Thiazolone and Thiazolthione Scafold with Apoptotic Activity

    by Nour E. A. Abd El-Sattar, Eman H. K. Badawy, Wafaa H. AbdEl-Hady, Mohamed I. Abo-Alkasem, Asmaa A. Mandour, Nasser S. M. Ismail

    Cyclin dependent kinase 2 (CDK2) inhibition is a well-established strategy for treating cancer. Different series of novel thiazolone (1, 7–9) together with fused thiazolthione (2–6, and 10) derivatives were designed, then synthesized and evaluated for their biological inhibitory activity against CDK2. Additionally, the cytotoxicity of the new compounds was explored against breast and colon cancer cell lines. The novel thiazolone and the fused thiazolthione derivatives exhibited potent CDK2/cyclin A2 inhibitory effect of an IC50 values ranging 105.39–742.78 nM. Amongst them compounds 4 and 6 revealed highest IC50 of 105.39 and 139.27 nM, respectively. Most compounds showed significant inhibition on both breast cancer and colon cancer cell lines with IC50 range 0.54–5.26 and 0.83–278 µM, respectively. Further investigations involved flow cytometry analysis on MCF-7 cancer cell line for compounds 5 and 7 which resulted in arrest cell-cycle at two phases Pre G1/G2-M and re-enforced apoptosis via activation of caspase-7. Molecular modeling simulation of the designed compounds revealed that they were well fitted into CDK2 active site and their complexes were stabilized through the essential hydrogen bonding. Three dimensional quantitative structure activity relationship (3D QSAR) pharmacophore, and absorption, distribution, metabolism, excretion, and toxicity (ADMET) studies were also carried out showing proper pharmacokinetic and drug-likeness which aided in the prediction of the structure requirements responsible for the observed antitumor activity.


  • Piloquinone, potent cytotoxic compound from Egyptian Streptomyces pilosus SBG-NRC-216

    by Hassan M Awad, MohamedI Abo-Alkasem, AhmedA El-Beih, TarekE Mazeed, Enas M Mostafa, SamiaA Ahmed, Saadia M Easa, Fawkia M El-Beih, AhmedI El-Diwany

    Background and objective Piloquinone shows biological activity as an anticancer and antitrypanosomal agent, and it acts as an inhibitor for monoamine oxidase, the main causative factor of Alzheimer’s disease. The aim of this study was to produce Piloquinone as a bioactive compound from a local Streptomyces isolate for many medical purposes. Materials and methods Fifty Streptomyces isolates for their capacity of Piloquinone production were tested. The potent Piloquinone producer, SBG-NRC-216 isolate, was identified by conventional and genetic methods. The produced compound was purified and identified on the basis of the spectroscopic analysis. A series of experiments were conducted to investigate efficacy of the compound. Results and conclusion The producer isolate was identified by phenotypic and genotypic methods. These methods confirmed that the strain name was Streptomyces pilosus SBG-NRC-216. The produced compound was purified and identified as Piloquinone. It showed a potent anticancer activity against five different human tumor cell lines: breast cancer cell line MCF-7, human liver cancer cell line HepG2, human lung cancer cell line A549 and human colon cancer cell lines Caco-2 and HCT-116. The results also indicated that Piloquinone had a weak antiviral activity against the H5N1 virus. The results proved that Piloquinone can be used as a bioactive compound that has many industrial and medical purposes.